Related references
Note: Only part of the references are listed.Cancer Statistics, 2018
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Effect of Aspirin on Cancer Chemoprevention in Japanese Patients With Type 2 Diabetes: 10-Year Observational Follow-up of a Randomized Controlled Trial
Sadanori Okada et al.
DIABETES CARE (2018)
Effects of chemopreventive agents on the incidence of recurrent colorectal adenomas: a systematic review with network meta-analysis of randomized controlled trials
Sajesh K. Veettil et al.
ONCOTARGETS AND THERAPY (2017)
Evaluation of PTGS2 Expression, PIK3CA Mutation, Aspirin Use and Colon Cancer Survival in a Population-Based Cohort Study
Ronan T. Gray et al.
CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY (2017)
Integration of pharmacology, molecular pathology, and population data science to support precision gastrointestinal oncology
Shuji Ogino et al.
NPJ PRECISION ONCOLOGY (2017)
Validation of low-dose aspirin prescription data in The Health Improvement Network: how much misclassification due to over-the-counter use?
Lucia Cea Soriano et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2016)
Aspirin Use for the Primary Prevention of Cardiovascular Disease and Colorectal Cancer: US Preventive Services Task Force Recommendation Statement
Kirsten Bibbins-Domingo
ANNALS OF INTERNAL MEDICINE (2016)
ADD-ASPIRIN: A phase III, double-blind, placebo controlled, randomised trial assessing the effects of aspirin on disease recurrence and survival after primary therapy in common non-metastatic solid tumours
Christopher Coyle et al.
CONTEMPORARY CLINICAL TRIALS (2016)
Aspirin, Calcitriol, and Calcium Do Not Prevent Adenoma Recurrence in a Randomized Controlled Trial
Hans-Christian Pommergaard et al.
GASTROENTEROLOGY (2016)
Aspirin use after diagnosis but not prediagnosis improves established colorectal cancer survival: a meta-analysis
Peiwei Li et al.
GUT (2015)
The preventive effects of low-dose enteric-coated aspirin tablets on the development of colorectal tumours in Asian patients: a randomised trial
Hideki Ishikawa et al.
GUT (2014)
Use of aspirin post-diagnosis in a cohort of patients with colorectal cancer and its association with all-cause and colorectal cancer specific mortality
C. McCowan et al.
EUROPEAN JOURNAL OF CANCER (2013)
Competing risks in epidemiology: possibilities and pitfalls
Per Kragh Andersen et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2012)
Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: analysis of the time course of risks and benefits in 51 randomised controlled trials
Peter M. Rothwell et al.
LANCET (2012)
Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trials
Annemijn M. Algra et al.
LANCET ONCOLOGY (2012)
Molecular pathological epidemiology of colorectal neoplasia: an emerging transdisciplinary and interdisciplinary field
Shuji Ogino et al.
GUT (2011)
Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials
Peter M. Rothwell et al.
LANCET (2011)
Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial
John Burn et al.
LANCET (2011)
Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials
Peter M. Rothwell et al.
LANCET (2010)
Aspirin Use and Survival After Diagnosis of Colorectal Cancer
Andrew T. Chan et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Aspirin for the Chemoprevention of Colorectal Adenomas: Meta-analysis of the Randomized Trials
Bernard F. Cole et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies
Enrico Flossmann et al.
LANCET (2007)
Effect of aspirin on the Wnt/β-catenin pathway is mediated via protein phosphatase 2A
C. L. Bos et al.
ONCOGENE (2006)
Daily soluble aspirin and prevention of colorectal adenoma recurrence: One-year results of the APACC trial
R Benamouzig et al.
GASTROENTEROLOGY (2003)
A randomized trial of aspirin to prevent colorectal adenomas
JA Baron et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer
RS Sandler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Share Paper
